Startseite>>Signaling Pathways>> Obesity, Appetite Control & Diabetes>> Diabetes>>Fascaplysin (chloride)

Fascaplysin (chloride) (Synonyms: NSC 622398)

Katalog-Nr.GC18693

Fascaplysin (Chlorid) ist ein antimikrobieller und zytotoxischer roter Farbstoff, der aus dem Meeresschwamm (Fascaplysin (Chlorid)opsis sp.

Products are for research use only. Not for human use. We do not sell to patients.

Fascaplysin (chloride) Chemische Struktur

Cas No.: 114719-57-2

Größe Preis Lagerbestand Menge
1mg
68,00 $
Auf Lager
5mg
271,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 1 publications

Description Chemical Properties Product Documents Related Products
Fascaplysin is an inhibitor of cyclin D kinase 4/ cyclin D1 (IC50 = 0.35 μM) that was originally isolated from the marine sponge Thorectandra. It is significantly less selective for Cdk6/cyclin D1 (IC50 = 3.4 μM) and does not inhibit other Cdks and tyrosine kinases. Fascaplysin is reported to have antiproliferative activity against retinoblastoma-positive tumor cells, blocking retinoblastoma phosphorylation and inducing G1 arrest. Inhibition of Cdk4 via fascaplysin has been shown to induce peroxisome-proliferator-activated receptor γ-1α deacetylation (IC50 = 0.7 uM) and has been used to demonstrate a role for insulin-activated cyclinD1-Cdk4 signaling in the control of glucose metabolism.

Bewertungen

Review for Fascaplysin (chloride)

Average Rating: 5 ★★★★★ (Based on Reviews and 20 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Fascaplysin (chloride)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.